Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Income from Continuing Operations (2013 - 2026)

Updated

Regen BioPharma (RGBP) recorded Income from Continuing Operations of -$637,785 in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$167,292 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Income from Continuing Operations (2013 - 2026) Analysis & Trends

On a TTM basis, Regen BioPharma's Income from Continuing Operations came in at -$2.35 million as of Jun 30, 2026; for FY2025 (ended Sep 30, 2025), it was -$1.27 million.

  • Across earlier fiscal years, Income from Continuing Operations came in at -$668,255 in FY2024, $1.16 million in FY2023, -$477,870 in FY2022 and -$516,784 in FY2021.
  • Quarterly Income from Continuing Operations has ranged from -$967,853 in fiscal Q1 2026 to -$19,354 in fiscal Q2 2025 over the past five years.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -637,785.00
Dec 31, 2025 -967,853.00
Sep 30, 2025 -572,469.00
Jun 30, 2025 -167,292.00
Mar 31, 2025 -19,354.00
Dec 31, 2024 -515,384.00
Sep 30, 2024 -270,748.00
Jun 30, 2024 -130,120.00
Mar 31, 2024 -122,454.00
Dec 31, 2023 -144,932.00
Sep 30, 2023 -74,164.00
Jun 30, 2023 -99,218.00
Mar 31, 2023 -90,927.00
Dec 31, 2022 -481,226.00
Sep 30, 2022 -128,529.00
Jun 30, 2022 -89,309.00
Mar 31, 2022 -119,055.00
Dec 31, 2021 -141,432.00
Sep 30, 2021 -244,810.00
Jun 30, 2021 -102,060.00
API Access

Regen BioPharma Inc Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RGBP&period=max&api_key=YOUR_API_KEY